about
Overexpression of the multidrug resistance-associated protein (MRP1) in human heavy metal-selected tumor cells5-Aza-2'-deoxycytidine sensitizes busulfan-resistant myeloid leukemia cells by regulating expression of genes involved in cell cycle checkpoint and apoptosis.Adenosine triphosphate-dependent transport of doxorubicin, daunomycin, and vinblastine in human tissues by a mechanism distinct from the P-glycoprotein.Ribozyme-mediated reversal of the multidrug-resistant phenotype.p53-independent apoptosis induced by paclitaxel through an indirect mechanism.Ribozyme-mediated cleavage of the MDR-1 transcript restores chemosensitivity in previously resistant cancer cells.Image-guided nanosystems for targeted delivery in cancer therapy.Preferential expression of a mutant allele of the amplified MDR1 (ABCB1) gene in drug-resistant variants of a human sarcoma.Pharmacogenomics of second-line drugs used for treatment of unresponsive or relapsed osteosarcoma patients.Increased expression of multidrug resistance related proteins Pgp, MRP1, and LRP/MVP occurs early in colorectal carcinogenesis.P-glycoprotein: clinical significance and methods of analysis.Modified multiple drug resistance phenotype of Chinese hamster ovary cells selected with X-rays and vincristine versus X-rays onlyRole of glutathione, glutathione S-transferases and multidrug resistance-related proteins in cisplatin sensitivity of head and neck cancer cell lines.Immunohistochemical detection of P-glycoprotein in formalin-fixed and paraffin-embedded normal and neoplastic canine tissues.Comparison of the expression of P-glycoprotein, Ki-67, and P-53 to technetium-99m tetrofosmin mammoscintigraphic findings.Relation between cellular doxorubicin binding ability to nuclear DNA and histologic response to preoperative chemotherapy in patients with osteosarcoma.Ependymomas in children express the multidrug resistance gene: immunohistochemical and molecular biologic study.Different effects of FK317 on multidrug-resistant tumor in vivo and in vitro.
P2860
Q28369884-AA1AD618-D105-4D42-A5E7-495069C55D0CQ33665187-C286F6DB-AE26-4CF9-BE0F-A7CDB19F6B3EQ34130602-7BEA2120-349A-46A4-825E-1ECED5476B07Q35897342-F3705DDD-0058-4446-A285-E2653CFE8BA4Q36573439-0040393A-AE74-4787-A99C-2292A912C1C9Q37636860-2DD48F15-AE29-48F1-9031-3DAD7F109A77Q38011794-AF3FCFBD-4ADD-45FC-ACE9-FFDC570B5D20Q38488434-9C48FC45-9D14-4BD7-81B9-C956666095FDQ38791215-02009327-2171-40A7-853C-2D84DD11D12AQ39617875-34A57355-8E53-4A4F-9657-A99A374F1615Q40380366-61044E30-F86B-495A-AE0C-B85F1EF85DBAQ41478424-F89CC51D-A86D-4FBD-AC4D-72139C909EB1Q42207013-53E4C9A7-F2A5-48EA-B485-B73187131EA1Q42525924-6E1589CE-F201-4893-95F4-CB7454CD3FFAQ43922191-067CA7A8-9970-432F-8BF9-EB7D5DB522ACQ47945205-067AF670-0471-43F6-8A03-DF8AA8B8F35BQ48967954-DDC0ED5F-6D9E-4360-905B-16CF2B53A815Q55256341-D37F903A-B8DE-4EF0-BDB6-F329748357F1
P2860
description
1992 nî lūn-bûn
@nan
1992 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1992 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
name
Genetic aspects of multidrug resistance.
@ast
Genetic aspects of multidrug resistance.
@en
type
label
Genetic aspects of multidrug resistance.
@ast
Genetic aspects of multidrug resistance.
@en
prefLabel
Genetic aspects of multidrug resistance.
@ast
Genetic aspects of multidrug resistance.
@en
P2860
P1433
P1476
Genetic aspects of multidrug resistance.
@en
P2093
Biedler JL
P2860
P304
P356
10.1002/1097-0142(19920915)70:4+<1799::AID-CNCR2820701623>3.0.CO;2-B
P407
P433
P577
1992-09-01T00:00:00Z